询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
6,7-Dimethoxy-3H-1-isobenzofuranone | CAS:569-31-3
6,7-Dimethoxy-3H-1-isobenzofuranone
  • 名称:6,7-二甲氧基-3H-1-异苯并呋喃酮 | 6,7-Dimethoxy-3H-1-isobenzofuranone
  • CAS号:569-31-3
  • 别名:
  • 分子式:C10H10O4
  • 分子量:194.18
  • EINESC号:209-311-8

产品描述

物理化学性质

熔点 103 ºC**
密度 1.260±0.06 g/cm3 (20 º

安全数据

没有数据没有数据

SDS

来源 SDS样本
没有数据没有数据
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.A Guerra et al.European journal of medicinal chemistry, 45(3), 930-940 (2009-12-22) A microdialysis study of oral vigabatrin administration in head injury patients: preliminary evaluation of multimodality monitoring.Keri L H Carpenter et al.Acta neurochirurgica. Supplement, 114, 271-276 (2012-04-06) Cerebellar fastigial nuclear GABAergic projections to the hypothalamus modulate immune function.Bei-Bei Cao et al.Brain, behavior, and immunity, 27(1), 80-90 (2012-10-11) Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.C Y Go et al.Neurology, 78(24), 1974-1980 (2012-06-13) Vigabatrin pediatric dosing information for refractory complex partial seizures: results from a population dose-response analysis.Jace C Nielsen et al.Epilepsia, 55(12), e134-e138 (2014-10-15) Vigabatrin for infantile spasms.Kimberly A Pesaturo et al.Pharmacotherapy, 31(3), 298-311 (2011-03-03) Analysis of vigabatrin treatment causing visual field defects in infantile spasms.Catherine Chiron et al.Developmental medicine and child neurology, 57(1), 9-10 (2014-08-12) Taurine is a crucial factor to preserve retinal ganglion cell survival.Nicolas Froger et al.Advances in experimental medicine and biology, 775, 69-83 (2013-02-09) Vigabatrin versus carbamazepine monotherapy for epilepsy.Yousheng Xiao et al.The Cochrane database of systematic reviews, 1, CD008781-CD008781 (2012-01-20) Vigabatrin therapy for refractory complex partial seizures: review of clinical trial experience in the United States.E Faught Acta neurologica Scandinavica. Supplementum, (192)(192), 29-35 (2011-11-09) Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.Milena Djuric et al.Epilepsia, 55(12), 1918-1925 (2014-11-08) Probing the steric requirements of the γ-aminobutyric acid aminotransferase active site with fluorinated analogues of vigabatrin.Jose I Juncosa et al.Bioorganic & medicinal chemistry, 21(4), 903-911 (2013-01-12) Infantile spasms (West syndrome): update and resources for pediatricians and providers to share with parents.James W Wheless et al.BMC pediatrics, 12, 108-108 (2012-07-27) Changes in the ERG d-wave with vigabatrin treatment in a pediatric cohort.Rachel Dragas et al.Documenta ophthalmologica. Advances in ophthalmology, 129(2), 97-104 (2014-07-11) A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence.Eugene C Somoza et al.JAMA psychiatry, 70(6), 630-637 (2013-04-12) Clinical reasoning: a case of abnormal eye movements in an infant: more than meets the eye.Lance H Rodan et al.Neurology, 81(15), e112-e115 (2013-10-09) Justification of vigabatrin administration in West syndrome patients? Warranting a re-consideration for improvement in their quality of life.Harinder Jaseja Clinical neurology and neurosurgery, 111(2), 111-114 (2008-10-11) Extensive astrocyte metabolism of γ-aminobutyric acid (GABA) sustains glutamine synthesis in the mammalian cerebral cortex.Jens V Andersen et al.Glia, 68(12), 2601-2612 (2020-06-26) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.Denis Fourches et al.Chemical research in toxicology, 23(1), 171-183 (2009-12-18) Primer on visual field testing, electroretinography, and other visual assessments for patients treated with vigabatrin.R C Sergott et al.Acta neurologica Scandinavica. Supplementum, (192)(192), 48-56 (2011-11-09) Recommendations for visual evaluations of patients treated with vigabatrin.Robert C Sergott Current opinion in ophthalmology, 21(6), 442-446 (2010-09-03) Ohtahara syndrome or early-onset West syndrome? A case with overlapping features and favorable response to vigabatrin.Christian M Korff et al.European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 16(6), 753-757 (2012-07-07) Vigabatrin-associated visual field loss.Chris Fecarotta et al.International ophthalmology clinics, 52(3), 87-94 (2012-06-07) FT-Raman, FT-IR and UV-visible spectral investigations and ab initio computations of anti-epileptic drug: vigabatrin.Bismi Edwin et al.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 114, 633-641 (2013-07-03) The effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl-GABA and ethanolamine-O-sulphate on the in vivo release of GABA from rat hippocampus.M Qume et al.Journal of neurochemistry, 64(5), 2256-2261 (1995-05-01) [Ocular toxicity of drugs].Isabelle Audo La Revue du praticien, 63(1), 63-67 (2013-03-06) Chemical genetics reveals a complex functional ground state of neural stem cells.Phedias Diamandis et al.Nature chemical biology, 3(5), 268-273 (2007-04-10) Visual field and ocular safety during short-term vigabatrin treatment in cocaine abusers.Tamara L Berezina et al.American journal of ophthalmology, 154(2), 326-332 (2012-06-19) Outcomes of epileptic spasms in patients aged less than 3 years: single-center United States experience.Martina Vendrame et al.Pediatric neurology, 46(5), 276-280 (2012-04-24) Vigabatrin therapy for refractory complex partial seizures: review of major European trials.E Ben-Menachem et al.Acta neurologica Scandinavica. Supplementum, (192)(192), 16-28 (2011-11-09) [The course and treatment of epilepsy in children with tuberose sclerosis].M Iu Dorofeeva et al.Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 112(6 Pt 2), 27-31 (2012-09-18) An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms.Choong Yi Fong et al.Developmental medicine and child neurology, 55(9), 862-867 (2013-06-25) Medical management of refractory epilepsy--practical treatment with novel antiepileptic drugs.Elinor Ben-Menachem Epilepsia, 55 Suppl 1, 3-8 (2014-01-10) Patterns of peripapillary retinal nerve fiber layer thinning in vigabatrin-exposed individuals.Lisa M Clayton et al.Ophthalmology, 119(10), 2152-2160 (2012-08-03) The potential value of a negative finding: an illustrative example.Kenneth Silverman et al.JAMA psychiatry, 70(6), 571-572 (2013-04-12) Vigabatrin-induced forced normalization and psychosis--prolongated termination of behavioral symptoms but persistent antiepileptic effect after withdrawal.Peter Weber et al.Epilepsy & behavior : E&B, 24(1), 138-140 (2012-04-17) Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing.L Carmant Acta neurologica Scandinavica. Supplementum, (192)(192), 36-47 (2011-11-09) Vigabatrin monotherapy for infantile spasms.Eija Gaily Expert review of neurotherapeutics, 12(3), 275-286 (2012-03-01) Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review.Melissa J Maguire et al.Epilepsia, 51(12), 2423-2431 (2010-11-13) Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study.Raili Riikonen et al.Developmental medicine and child neurology, 57(1), 60-67 (2014-08-26) [Therapeutic drug monitoring of vigabatrin].Danièle Bentué-Ferrer et al.Therapie, 65(1), 23-27 (2010-03-09) Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex.Bo Zhang et al.PloS one, 8(2), e57445-e57445 (2013-02-26) Vigabatrin for refractory partial epilepsy.Karla Hemming et al.The Cochrane database of systematic reviews, 1(1), CD007302-CD007302 (2013-02-27) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).Zhichao Liu et al.PLoS computational biology, 7(12), e1002310-e1002310 (2011-12-24) Mechanism of action of vigabatrin: correcting misperceptions.E Ben-Menachem Acta neurologica Scandinavica. Supplementum, (192)(192), 5-15 (2011-11-09) Vigabatrin: 2008 update.L James Willmore et al.Epilepsia, 50(2), 163-173 (2009-02-21) Sildenafil influences the anticonvulsant activity of vigabatrin and gabapentin in the timed pentylenetetrazole infusion test in mice.Dorota Nieoczym et al.Progress in neuro-psychopharmacology & biological psychiatry, 39(1), 129-135 (2012-06-12) Balancing clinical benefits of vigabatrin with its associated risk of vision loss.J M Pellock Acta neurologica Scandinavica. Supplementum, (192)(192), 83-91 (2011-11-09) [Pharmacological treatment of spasticity in multiple sclerosis].O Heinzlef et al.Revue neurologique, 168 Suppl 3, S62-S68 (2012-06-29) Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex.Daniel Friedman et al.Epilepsy & behavior : E&B, 27(1), 118-120 (2013-02-13) Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval.Justin A Tolman et al.Expert opinion on pharmacotherapy, 10(18), 3077-3089 (2009-12-04) Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures.Mi-Sun Yum et al.Journal of child neurology, 28(3), 308-313 (2012-07-04) Effects of vigabatrin on the skeletal system of young rats.Barbara Nowińska et al.Acta poloniae pharmaceutica, 69(2), 327-334 (2012-05-10) Non-vision adverse events with vigabatrin therapy.S D Walker et al.Acta neurologica Scandinavica. Supplementum, (192)(192), 72-82 (2011-11-09) Vigabatrin-associated retinal damage: potential biochemical mechanisms.M K Heim et al.Acta neurologica Scandinavica, 126(4), 219-228 (2012-05-29) Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.Yun W Alelyunas et al.Bioorganic & medicinal chemistry letters, 20(24), 7312-7316 (2010-11-09) Understanding and interpreting vision safety issues with vigabatrin therapy.G T Plant et al.Acta neurologica Scandinavica. Supplementum, (192)(192), 57-71 (2011-11-09) Animal models of the epilepsies.R S Fisher Brain research. Brain research reviews, 14(3), 245-278 (1989-07-01) Infantile spasms (West syndrome): update and resources for pediatricians and providers to share with parents.James W Wheless et al.BMC pediatrics, 12, 108-108 (2012-07-27) Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.Milena Djuric et al.Epilepsia, 55(12), 1918-1925 (2014-11-08)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交